![(2R)-2-[4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thiophen-4-yl)-2,6-dimethylphenoxy]-3-phenylpropanoic…](https://static.cymitquimica.com/cas-image/328073-2r-2-4-9-bromo-23-dimethylnaphtho-23-b-thiophen-4-yl-26-dimethylphenoxy-3-phenylpropanoic-acid.png)
CAS: 251303-04-5 - (2R)-2-[4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thiophen-4-yl)-2,6-dimethylphenoxy]-3-phenylpropanoic acid
Formula:C31H27BrO3S
InChI:InChI=1/C31H27BrO3S/c1-17-14-22(15-18(2)29(17)35-25(31(33)34)16-21-10-6-5-7-11-21)27-23-12-8-9-13-24(23)28(32)30-26(27)19(3)20(4)36-30/h5-15,25H,16H2,1-4H3,(H,33,34)/t25-/m1/s1
- Synonyms:
- benzenepropanoic acid, alpha-[4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thien-4-yl)-2,6-dimethylphenoxy]-, (alphaR)-
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Ertiprotafib REF: TR-E635085CAS: 251303-04-5 | - - - | 15,266.00 € | Fri 27 Dec 24 |
 | Ertiprotafib REF: 3D-BKA30304CAS: 251303-04-5 | Min. 95% | To inquire | Fri 27 Dec 24 |
 | Ertiprotafib REF: TM-T15243CAS: 251303-04-5 | 98.38% | To inquire | Fri 03 Jan 25 |
Ertiprotafib
Controlled ProductCAS:251303-04-5
Formula:
C31H27BrO3S
Color and Shape:
Neat
Molecular weight:
559.513
Ref: TR-E635085
| 75mg | 15,266.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
Ertiprotafib
CAS:251303-04-5
Ertiprotafib is a natural drug that inhibits the activity of enzymes involved in the synthesis …
Formula:
C31H27BrO3S
Purity:
Min. 95%
Molecular weight:
559.5 g/mol
Ref: 3D-BKA30304
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
Ertiprotafib
CAS:251303-04-5
Ertiprotafib (PTP 112), a PTP1B and IKK-β inhibitor, is a novel insulin sensitizer for the …
Formula:
C31H27BrO3S
Purity:
98.38%
Color and Shape:
Solid
Molecular weight:
559.51
Ref: TM-T15243
| 1mg | 89.00 € | ||
| 5mg | 182.00 € | ||
| 10mg | 318.00 € | ||
| 25mg | 623.00 € | ||
| 50mg | 921.00 € | ||
| 100mg | 1,216.00 € |
Estimated delivery in United States, on Friday 3 Jan 2025
